Outcomes of simultaneous kidney-pancreas transplantation with positive cross-match.

Heilman, R L; Chakkera, H; Mazur, M; Petrides, S; Moss, A; Mekeel, K; Mulligan, D; Reddy, K S

Heilman, R L; Chakkera, H; Mazur, M; Petrides, S; Moss, A; Mekeel, K; Mulligan, D; Reddy, K S.

Affiliation

Heilman RL; Division of Nephrology and Hypertension and Transplant Medecine, The Mayo Clinic, Rochester, Minnesota 55905, USA.

Transplant Proc ; 41(1): 303-6, 2009.

Article in En | MEDLINE | ID: mdl-19249540

Subject(s)

Kidney Transplantation/immunology; Pancreas Transplantation/immunology; Alemtuzumab; Antibodies, Monoclonal/therapeutic use; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm/therapeutic use; Antilymphocyte Serum/therapeutic use; Drug Therapy, Combination; Follow-Up Studies; Graft Survival/immunology; Histocompatibility Testing; Humans; Immunoglobulins, Intravenous/therapeutic use; Immunosuppressive Agents/therapeutic use; Kidney Transplantation/mortality; Pancreas Transplantation/mortality; Retrospective Studies; Survival Analysis; Time Factors; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Kidney Transplantation / Pancreas Transplantation Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Transplant Proc Year: 2009 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google